Position in DGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$149,000
+$11,227 QoQ
Shares Held
703
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#847
of 1,090 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Salomon & Ludwin, LLC holds $713,362 across 18 Diagnostics & Research names. DGX ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
This page
|
703 | $149,000 | |
| 2 | WAT |
Waters Corp /De/
|
354 | $132,764 | |
| 3 | DHR |
Danaher Corp /De/
|
550 | $104,764 | |
| 4 | VCYT |
Veracyte, Inc.
|
880 | $51,682 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
97 | $48,631 | |
| 6 | A |
Agilent Technologies, Inc.
|
363 | $48,217 | |
| 7 | RDNT |
RadNet, Inc.
|
593 | $36,570 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
24 | $30,660 |
All Filings in DGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,000 | 703 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $137,773 | 703 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $121,991 | 703 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $137,408 | 721 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $3,233 | 18 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,045 | 18 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,715 | 18 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,794 | 18 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,927 | 36 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,395 | 18 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $24,266 | 176 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $21,447 | 176 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||